Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemoradiotherapy with metformin for locally advanced pancreatic cancer
jRCTs011180011Active, not recruiting
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metformin in pancreatic cancer (PC) and type 2 diabetes mellitus (T2DM). Primary endpoint: Histological residual cancer cell ratio. Started Jul 2015; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
pancreatic cancer (PC)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCTs011180011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011180011.